Radiation Exposure Could Be Countered By Ingesting Ex-Rad Pills

December 11, 2012

Biology

nuclear-bomb

The US Department of Defense has been developing pills that will protect humans from radiation. The pills are named Ex-Rad and were developed by Onconova Therapeutics in conjunction with the DoD.

The scientists published their findings in the journal Radiation Research. Once humans have been exposed to radiation, there hasn’t been much they could do to protect themselves, besides evacuating the area.

Ex-Rad increases the likelihood that the human body will survive radiation exposure. It can be taken orally or intravenously. The drug increases the chances of survival when the body is exposed to a potential lethal dose of radiation. The drug can be taken before or after exposure. Studies in mice have shown that the drug conferred protection from a lethal dose of gamma radiation. Human trials didn’t include radiation, but showed that the drug wasn’t harmful and had no side effects.

Ex-Rad seems to alter the way that cells deal with DNA damage. It suppresses the protein p53 that triggers cell death. This kind of drug has been seen in science fiction video games for at least a decade. In the game Fallout, players use a radiation drug called Rad-X.

[via i09]

Email
, , , ,

Subscribe / Follow

Don't miss out. Follow the latest technology & science news via email or social media.

3 Responses to “Radiation Exposure Could Be Countered By Ingesting Ex-Rad Pills”

  1. fred Says:

    these pills will be great to have availiable when a nuke plant melts down and radeates pepole that work or live nere by,like japans nuke plant. it will be great to have in a nuke attact,to help save lives.but the question is do they really work?

    Reply

  2. Cobalt Says:

    I still think Rad-X sounds better.
    Still, I never would have imagined having technology like this in my lifetime. These could be incredibly useful in the event of a nuclear disaster.

    Reply

  3. Bob Says:

    This is f-ing sketch

    Reply

Leave a Reply